Approvals/TGA/CIPLA HYDROCORTISONE hydrocortisone (as sodium succinate) 100 mg powder for injection vial

Approved

STANDARD

CIPLA HYDROCORTISONE hydrocortisone (as sodium succinate) 100 mg powder for injection vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6c334ed8cdb8b7fb
Product Name: CIPLA HYDROCORTISONE hydrocortisone (as sodium succinate) 100 mg powder for injection vial
Artg Id: 373394
Artg Name: CIPLA HYDROCORTISONE hydrocortisone (as sodium succinate) 100 mg powder for injection vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2022-06-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/b206c9d7680d97a80d3e2abeddfdbc28.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

6c334ed8cdb8b7fb

Type

Standard